Ovarian Cancer

EP. 1: Adjuvant Chemotherapy + Bevacizumab for Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 2: An Overview of PARP Inhibitors in Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 3: Pivotal Trials in the Realm of Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 4: Case 1: Diagnostic Tissue Testing in Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 5: Case 1: Use of Maintenance Therapy in Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 6: Case 1: Observation Versus Maintenance Therapy in Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 7: Case 1: Impact of Biomarkers on Maintenance Therapy

ByTargeted Oncology

June 25th 2020

EP. 8: Case 1: Use of Niraparib in Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 9: Case 2: Adding Bevacizumab to Chemotherapy in Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 10: Case 2: Maintenance in BRCA1/2wt, HR-Proficient Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 11: Case 3: Second-Line Therapy for Recurrent Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 12: Case 3: Maintenance Therapy for Recurrent Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 13: Case 3: The OCEANS and GOG-0213 Trials for Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 14: Case 3: Benefit of PARP Inhibitor Maintenance in Ovarian Cancer

ByTargeted Oncology

June 25th 2020

EP. 15: Treating Ovarian Cancer With a PFI Less Than 6 Months

ByTargeted Oncology

June 25th 2020

EP. 16: Trials of Interest in Ovarian Cancer

ByTargeted Oncology

June 25th 2020